Maven Securities LTD Inhibrx, Inc. Transaction History

Maven Securities LTD

  • $774 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$25.18 - $37.81 $397,844 - $597,398
-15,800 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$14.69 - $27.52 $232,102 - $434,816
15,800 New
15,800 $439,000
Q4 2020

Feb 12, 2021
SELL
$15.96 - $50.0 $166,319 - $521,050
-10,421 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$16.77 - $20.65 $174,760 - $215,193
10,421 New
10,421 $185,000

Others Institutions Holding INBX

# of Institutions
1
Shares Held
18.6K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $603M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Maven Securities LTD Portfolio

Follow Maven Securities LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email